Accurate MHC motif deconvolution of immunopeptidomics data reveals a significant contribution of DRB3, 4 and 5 to the total DR immunopeptidome

S Kaabinejadian, C Barra, B Alvarez, H Yari… - Frontiers in …, 2022 - frontiersin.org
Mass spectrometry (MS) based immunopeptidomics is used in several biomedical
applications including neo-epitope discovery in oncology, next-generation vaccine …

Oktoberfest: Open‐source spectral library generation and rescoring pipeline based on Prosit

M Picciani, W Gabriel, VG Giurcoiu, O Shouman… - …, 2024 - Wiley Online Library
Abstract Machine learning (ML) and deep learning (DL) models for peptide property
prediction such as Prosit have enabled the creation of high quality in silico reference …

Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools

M Prachar, S Justesen, DB Steen-Jensen… - Scientific reports, 2020 - nature.com
The outbreak of SARS-CoV-2 (2019-nCoV) virus has highlighted the need for fast and
efficacious vaccine development. Stimulation of a proper immune response that leads to …

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

A Nagler, S Kalaora, C Barbolin, A Gangaev… - Cell Reports, 2021 - cell.com
The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological
signature that can be selectively recognized by T cells. As viruses evolve by acquiring …

IEAtlas: an atlas of HLA-presented immune epitopes derived from non-coding regions

Y Cai, D Lv, D Li, J Yin, Y Ma, Y Luo, L Fu… - Nucleic acids …, 2023 - academic.oup.com
Cancer-related epitopes can engage the immune system against tumor cells, thus exploring
epitopes derived from non-coding regions is emerging as a fascinating field in cancer …

MR1 antigen presentation to MAIT cells and other MR1-restricted T cells

HEG McWilliam, JA Villadangos - Nature Reviews Immunology, 2024 - nature.com
MHC antigen presentation plays a fundamental role in adaptive and semi-invariant T cell
immunity. Distinct MHC molecules bind antigens that differ in chemical structure, origin and …

Progress identifying and analyzing the human proteome: 2021 metrics from the HUPO human proteome project

GS Omenn, L Lane, CM Overall, YK Paik… - Journal of proteome …, 2021 - ACS Publications
The 2021 Metrics of the HUPO Human Proteome Project (HPP) show that protein expression
has now been credibly detected (neXtProt PE1 level) for 18 357 (92.8%) of the 19 778 …

Challenges and solutions for therapeutic TCR‐based agents

M Malviya, ZEH Aretz, Z Molvi, J Lee… - Immunological …, 2023 - Wiley Online Library
Recent development of methods to discover and engineer therapeutic T‐cell receptors
(TCRs) or antibody mimics of TCRs, and to understand their immunology and …

Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond

S Pagliuca, C Gurnari, MT Rubio, V Visconte… - Frontiers in …, 2022 - frontiersin.org
Structural and functional variability of human leukocyte antigen (HLA) is the foundation for
competent adaptive immune responses against pathogen and tumor antigens as it assures …

Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions

W Lotter, MJ Hassett, N Schultz, KL Kehl, EM Van Allen… - Cancer Discovery, 2024 - AACR
Artificial intelligence (AI) in oncology is advancing beyond algorithm development to
integration into clinical practice. This review describes the current state of the field, with a …